Dechra Pharmaceuticals (DPH)

Sector:

Pharma and Biotech

Index:

FTSE 250

5,035.00p
   
  • Change Today:
      5.00p
  • 52 Week High: 5,405.00
  • 52 Week Low: 3,182.00
  • Currency: UK Pounds
  • Shares Issued: 108.35m
  • Volume: 23,657
  • Market Cap: £5,455m
  • RiskGrade: 121
  • Beta: 0.27

Dechra Pharma profits up as pet care rises during lockdown

By Frank Prenesti

Date: Monday 06 Sep 2021

LONDON (ShareCast) - (Sharecast News) - Veterinary drug maker Dechra Pharmaceuticals reported a surge in profits and lifted its dividend as people spent more on pet welfare during Covid-19 lockdowns.
The company on Monday said underlying operating profit increased by 29.2% to £162.2m on the back of revenue growth of 21.0% to £608.0m. The full-year dividend rose 18.1% to 40.50p a share.

On a pre-tax basis profit for the year through to June 30 almost doubled to £74m, up from £40.9m.

"We have benefited from above average market growth in the majority of our key companion animal product markets. The reasons for this market growth are not yet fully defined," said chief executive Ian Page.

"In the UK there have been reports of an increased number of dogs; however, recent information from the United States indicates that veterinary practice visits by pet owners have marginally declined."

"What is clear is that people have been spending more time with their pets and have therefore been more cognitive of their welfare, and with disposable income being higher than normal due to lockdown, expenditure per pet has increased."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

DPH Market Data

Currency UK Pounds
Share Price 5,035.00p
Change Today 5.00p
% Change 0.10 %
52 Week High 5,405.00
52 Week Low 3,182.00
Volume 23,657
Shares Issued 108.35m
Market Cap £5,455m
Beta 0.27
RiskGrade 121

DPH Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.62% below the market average99.62% below the market average99.62% below the market average99.62% below the market average99.62% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
87.96% above the market average87.96% above the market average87.96% above the market average87.96% above the market average87.96% above the market average
70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average
Income
61.57% below the market average61.57% below the market average61.57% below the market average61.57% below the market average61.57% below the market average
45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average
Growth
83.65% above the market average83.65% above the market average83.65% above the market average83.65% above the market average83.65% above the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 1
Strong Sell 1
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

DPH Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Oct-21 04-Mar-21
Paid 19-Nov-21 07-Apr-21
Amount 29.39p 11.11p

Trades for 03-Dec-2021

Time Volume / Share Price
10:44 75 @ 5,035.00p
10:44 52 @ 5,035.00p
10:44 80 @ 5,035.00p
10:44 75 @ 5,035.00p
10:44 17 @ 5,035.00p

DPH Key Personnel

CEO Ian Page
CFO Paul Sandland

Top of Page